New Canadian patent approval for Episurf Medical

REG

Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the Canadian Intellectual Property Office (CIPO). The patent, entitled "System and method for creating a decision support material indicating damage to an anatomical joint", relates to 3D-based assessment of joint lesions. 

"This is an important patent for Episurf in the field of medical imaging and surgical pre-planning, and we are happy to get it approved in strategically selected countries", says Katarina Flodström, COO, Episurf Medical.  

Datum 2023-04-03, kl 10:30
Källa Cision
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!